These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34628168)

  • 1. Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential.
    Kamyshnyi O; Matskevych V; Lenchuk T; Strilbytska O; Storey K; Lushchak O
    Biomed Pharmacother; 2021 Dec; 144():112230. PubMed ID: 34628168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes.
    Shao S; Yang Q; Pan R; Yu X; Chen Y
    Front Endocrinol (Lausanne); 2021; 12():731974. PubMed ID: 34690930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the interaction between COVID-19 and diabetes mellitus.
    Chee YJ; Tan SK; Yeoh E
    J Diabetes Investig; 2020 Sep; 11(5):1104-1114. PubMed ID: 32558211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role.
    Samuel SM; Varghese E; Büsselberg D
    Trends Microbiol; 2021 Oct; 29(10):894-907. PubMed ID: 33785249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19.
    Mashayekhi-Sardoo H; Hosseinjani H
    J Basic Clin Physiol Pharmacol; 2021 Jul; 33(1):17-25. PubMed ID: 34218545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
    Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
    Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs.
    Park MJ; Lee SY; Moon SJ; Son HJ; Lee SH; Kim EK; Byun JK; Shin DY; Park SH; Yang CW; Cho ML
    Transl Res; 2016 Jul; 173():115-130. PubMed ID: 27126953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism and application of metformin in kidney diseases: An update.
    Song A; Zhang C; Meng X
    Biomed Pharmacother; 2021 Jun; 138():111454. PubMed ID: 33714781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury.
    Chen X; Guo H; Qiu L; Zhang C; Deng Q; Leng Q
    Front Immunol; 2020; 11():2056. PubMed ID: 32973814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism.
    Hou Y; Yang Z; Xiang B; Liu J; Geng L; Xu D; Zhan M; Xu Y; Zhang B
    Sci Rep; 2024 May; 14(1):12406. PubMed ID: 38811809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers.
    Petakh P; Kamyshna I; Kamyshnyi A
    Inflammopharmacology; 2024 Feb; 32(1):885-891. PubMed ID: 37773574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of AMPK/mTOR signaling pathway in anticancer activity of metformin.
    Chomanicova N; Gazova A; Adamickova A; Valaskova S; Kyselovic J
    Physiol Res; 2021 Aug; 70(4):501-508. PubMed ID: 34062070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of metformin on glomerular podocytes in diabetes.
    Rogacka D; Piwkowska A
    Biochem Pharmacol; 2021 Oct; 192():114687. PubMed ID: 34274355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic.
    Gonikman D; Kustovs D
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893528
    [No Abstract]   [Full Text] [Related]  

  • 15. Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes.
    Crouse AB; Grimes T; Li P; Might M; Ovalle F; Shalev A
    Front Endocrinol (Lausanne); 2020; 11():600439. PubMed ID: 33519709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Suppresses Systemic Autoimmunity in
    Lee SY; Moon SJ; Kim EK; Seo HB; Yang EJ; Son HJ; Kim JK; Min JK; Park SH; Cho ML
    J Immunol; 2017 Apr; 198(7):2661-2670. PubMed ID: 28242651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of adverse in-hospital outcome and recovery in patients with diabetes mellitus and COVID-19 pneumonia in Iraq.
    Nafakhi H; Alareedh M; Al-Buthabhak K; Shaghee F; Nafakhi A; Kasim S
    Diabetes Metab Syndr; 2021; 15(1):33-38. PubMed ID: 33296788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy.
    Eisenreich A; Leppert U
    Curr Med Chem; 2017; 24(31):3397-3412. PubMed ID: 28393693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy.
    Shi WY; Xiao D; Wang L; Dong LH; Yan ZX; Shen ZX; Chen SJ; Chen Y; Zhao WL
    Cell Death Dis; 2012 Mar; 3(3):e275. PubMed ID: 22378068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19.
    Omarjee L; Perrot F; Meilhac O; Mahe G; Bousquet G; Janin A
    Aging (Albany NY); 2020 Dec; 12(24):26263-26278. PubMed ID: 33361522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.